ULCERATIVE COLITIS: RISK FACTORS
Keywords:
ulcerative colitis, risk factors, epidemiology, modern viewsAbstract
Ulcerative colitis (UL) is a chronic inflammation of the large intestine, which occurs mainly among working-age youth and has social significance. The incidence and prevalence of ulcerative colitis worldwide is 1.2-20.3% and 7.6-245 cases per 100,000 population per year, respectively. European studies have described the impact of ulcerative colitis on the quality and standard of life of patients, their employment, and their relationships with others. Late diagnosis of the disease, severe and complicated forms indicate its latent course.
References
Cohen R.D. et al. Systematic review: the costs of ulcerative colitis in Western countries // Aliment Pharmacol Ther . – 2010. - №31. – Р. 693–707.
Belousova E.A. et al. Infliximab: 10 years of successful use in inflammatory bowel diseases // Clinical Pharmacology and Therapy. - 2010. - No 19 (1). - P.50-54. (in Russian)
Subasinghe D. et al. Disease characteristics of inflammatory bowel disease (IBD). // J Gastrointest Surg . – 2011. - №15. – Р. 1562–1567.
Vatutin N. et al. Nonspecific ulcerative colitis // Archives of Internal Medicine. - 2015. - No4 (24). - P. 62-65. (in Russian)
Goroxova V.G. et al. Fecal calprotectin and intestinal microbiota // Acta Biomedica Scientifica. - 2016. - No1 (4). - No145-149. (in Russian)
Davidova O.E. Optimization of diagnosis and treatment of patients with severe forms of ulcerative colitis // abstract of the dissertation...14.01.17 - surgery. - 2019. - P.1-22 (in Russian)
Shivashankar R. et al. Incidence and prevalence of Crohn’s disease and ulcerative colitis in Olmsted County, Minnesota from 1970 through 2010 // Clin Gastroenterol Hepatol. – 2017. - №15. – Р. 857–863.
Dusanov A.D. et al. Clinical and immunological paralleles of nonspecific ulcerative colitis // Journal of Hepatogastroenterological Research. - 2020. - No1. - P. 34-37. (in Russian)
Bereznyak N.V. Clinical aspects of Crohn's disease // Abstract of the dissertation. - 2020. - Moscow. - P. 1-25. Sorogin S.A. Clinical and surgical aspects of ulcerative colitis // Diss. - 2023. - 161-p. (in Russian)
Khaydarov S.A. Ways to improve treatment tactics for nonspecific ulcerative colitis // Abstract of the dissertation. - Andijan. - 2021. - P. 1-50; (in Uzbek)
